Mira Johri

Mira Johri

Auto-generated profile, based on publicly available information

Mira Johri

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2008 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
SKSusan R. Kahn
Susan R. Kahn
ISIan Shrier
Ian Shrier
JJJim A. Julian
Jim A. Julian
TDThierry Ducruet
Thierry Ducruet
LALouise Arsenault
Louise Arsenault
JGJeffrey S. Ginsberg
Jeffrey S. Ginsberg
The reason some patients with deep venous thrombosis (DVT) develop the postthrombotic syndrome is not well understood. To determine the frequency, time course, and predictors of the postthrombotic syndrome after acute DVT. Prospective, multicenter cohort study. 8 Canadian hospital centers. 387 outpatients and inpatients who received an objective diagnosis of acute symptomatic DVT were recruited from 2001 to 2004. Standardized assessments for the postthrombotic syndrome using the Villalta scale at 1, 4, 8, 12, and 24 months after enrollment. Mean postthrombotic score and severity category at each interval was calculated. Predictors of postthrombotic score profiles over time since diagnosis of DVT were identified by using linear mixed modeling. At all study intervals, about 30% of patients had mild (score, 5 to 9), 10% had moderate (score, 10 to 14), and 3% had severe (score ##gt##14 or ulcer) postthrombotic syndrome. Greater postthrombotic severity category at the 1-month visit strongly predicted higher mean postthrombotic scores throughout 24 months of follow-up (1.97, 5.03, and 7.00 increase in Villalta score for mild, moderate, and severe 1-month severity categories, respectively, vs. none; P ##lt## 0.001). Additional predictors of higher scores over time were venous thrombosis of the common femoral or iliac vein (2.23 increase in score vs. distal [calf] venous thrombosis; P ##lt## 0.001), higher body mass index (0.14 increase in score per kg/m2; P ##lt## 0.001), previous ipsilateral venous thrombosis (1.78 increase in score; P= 0.001), older age (0.30 increase in score per 10-year age increase; P= 0.011), and female sex (0.79 increase in score; P= 0.020). Decisions to prescribe compression stockings were left to treating physicians rather than by protocol. Because international normalized ratio data were unavailable, the relationship between anticoagulation quality and Villalta scores could not be assessed. The postthrombotic syndrome occurs frequently after DVT. Patients with extensive DVT and those with more severe postthrombotic manifestations 1 month after DVT have poorer long-term outcomes.

1 March 2014 in The Lancet
Verified
Journal Article
Closed access
SKSusan R Kahn
Susan R Kahn
SSStan Shapiro
Stan Shapiro
PWPhilip S Wells
Philip S Wells
MRMarc A Rodger
Marc A Rodger
MKMichael J Kovacs
Michael J Kovacs
JGJeffrey S Ginsberg
Jeffrey S Ginsberg

28 June 2008 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
SKS. R. Kahn
S. R. Kahn
HSH. Shbaklo
H. Shbaklo
DLD. L. Lamping
D. L. Lamping
CHC. A. Holcroft
C. A. Holcroft
ISI. Shrier
I. Shrier
JGJ. S. Ginsberg
J. S. Ginsberg
Summary. Background/objectives: We prospectively measured change in quality of life (QOL) during the 2 years after a diagnosis of deep vein thrombosis (DVT) and evaluated determinants of QOL, including development of the post-thrombotic syndrome (PTS). Patients/methods: Consecutive patients with acute DVT were recruited from 2001 to 2004 at eight hospitals in Canada. At study visits at baseline, and 1, 4, 8, 12 and 24 months, clinical data were collected, standardized PTS assessments were performed, and QOL questionnaires were self-completed. Generic QOL was measured using the Short-Form Health Survey-36 (SF-36) questionnaire. Venous disease-specific QOL was measured using the Venous Insufficiency Epidemiological and Economic Study (VEINES)-QOL/Sym questionnaire. The change in QOL scores over a 2-year follow-up was assessed. The influence of PTS and other characteristics on QOL at 2 years was evaluated using multivariable regression analyses. Results: Among the 387 patients recruited, the average age was 56 years, two-thirds were outpatients, and 60% had proximal DVT. The cumulative incidence of PTS was 47%. On average, QOL scores improved during follow-up. However, patients who developed PTS had lower scores at all visits and significantly less improvement in QOL over time (P-values for PTS*time interaction were 0.001, 0.012, 0.014 and 0.006 for PCS, MCS, VEINES-QOL and VEINES-Sym). Multivariable regression analyses showed that PTS (P < 0.0001), age (P = 0.0009), proximal DVT (P = 0.01) and inpatient status (P = 0.04) independently predicted 2-year SF-36 PCS scores. PTS alone independently predicted 2-year VEINES-QOL (P < 0.0001) and VEINES-Sym (P < 0.0001) scores. Conclusions: Development of PTS is the principal determinant of health-related QOL 2 years after DVT. Our study provides prognostic information on patient-reported outcomes after DVT and emphasizes the need for effective prevention and treatment of the PTS.

12 March 2003 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
MJMira Johri
Mira Johri
FBFrancois Beland
Francois Beland
HBHoward Bergman
Howard Bergman

23 May 2005 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
SKSusan R. Kahn
Susan R. Kahn
TDThierry Ducruet
Thierry Ducruet
DLDonna L. Lamping
Donna L. Lamping
LALouise Arsenault
Louise Arsenault
MMMarie Jose Miron
Marie Jose Miron
ISIan Shrier
Ian Shrier
Deep venous thrombosis (DVT) is a common cardiovascular condition with substantial morbidity and mortality. Studies of the natural history or treatment of DVT have traditionally evaluated clinical end points such as recurrence of venous thromboembolism. While important, such end points are limited in their ability to describe and quantify the full impact of illness on patients’ health and daily functioning. Quality of life (QOL), by defining health in broader terms than morbidity and mortality, yields valuable information on burden of illness and is an important end point to consider when studying patients with DVT.1-4 To date, however, the impact of DVT on QOL has received little attention by thrombosis investigators.

1 October 2006 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
SKSusan R. Kahn
Susan R. Kahn
DLDonna L. Lamping
Donna L. Lamping
TDThierry Ducruet
Thierry Ducruet
LALouise Arsenault
Louise Arsenault
MMMarie José Miron
Marie José Miron
ISIan Shrier
Ian Shrier